New York, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neuromodulation Industry" - https://www.reportlinker.com/p05957502/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one yearGlobal Neuromodulation Market to Reach $8.9 Billion by 2027
- In the changed post COVID-19 business landscape, the global market for Neuromodulation estimated at US$5.1 Billion in the year 2020, is projected to reach a revised size of US$8.9 Billion by 2027, growing at a CAGR of 8.2% over the analysis period 2020-2027. Spinal Cord Stimulation, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$3.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Deep Brain Stimulation segment is readjusted to a revised 8.6% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 10% CAGR
- The Neuromodulation market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$663.5 Million by the year 2027 trailing a CAGR of 10% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.9% and 8.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.Sacral Nerve Stimulation Segment to Record 7.4% CAGR
- In the global Sacral Nerve Stimulation segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$696.3 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
Select Competitors (Total 83 Featured)
Abbott Laboratories
Aleva Neurotherapeutics SA
BioControl Medical
Bioness Inc
Boston Scientific Corporation
Cefaly
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic
Neuronetics
NeuroPace, Inc.
NeuroSigma, Inc.
Nevro Corporation
Respicardia, Inc
Stimwave LLC
Synapse Biomedical, Inc.
Read the full report: https://www.reportlinker.com/p05957502/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Neuromodulation - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Neurological Disorders
A Prelude to Neuromodulation
Indications for Neuromodulation Therapy
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
Global Neuromodulation Market Buckles under COVID-19 Strain
Effects of COVID-19 on the Nervous System Sheds Focus on
Neuromodulation Applications
GLOBAL MARKET OVERVIEW
Neuromodulation Market Set for a Robust Growth
Neuromodulation Market by Segment
Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS)
Represents the Largest Segments
Neuromodulation Devices by Technology
Spinal Cord Stimulation Market (2020): Dollar Market Share of
Leading Players in Percentage
Neuromodulation Market by Application
Growing Clinical Applications to Drive Demand
US and Europe Dominate the Market
Asia-Pacific and other Emerging Regions Display Impressive
Growth Potential
Competition
Select FDA Approved Neuromodulation Devices in Recent Years
Recent Market Activity
Market Restraints and Challenges
WORLD BRANDS
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
High Incidence of Neurological Disorders: A Key Market Driver
Annual Incidence of Adult-Onset Neurologic Disorders in the US
Rising Geriatric Population and Subsequent Growth in Prevalence
of Neurological Disorders
Global Population Statistics for the 65+ Age Group in Million
by Geographic Region for the Years 2019, 2025, 2035 and 2050
Growing Incidence of Neurodegenerative Diseases Propels the
Market for Deep Brain Stimulation Devices
Global Alzheimer’s Prevalence by Age Group
Diagnosed Prevalence Cases of Parkinson?s Disease Across Select
Countries
Global DBS Market by Leading Player (2020E): Market Share
Breakdown of Revenues for Medtronic, Boston Scientific, and
Abbott
Select Available Deep Brain Stimulation Devices Available in
the Market
Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve
Stimulation Devices
Epilepsy Incidence by Type (2019): Percentage Share Breakdown
for Idiopathic and Symptomatic Epilepsy
Symptomatic Epilepsy Incidence by Type (2019): Percentage Share
Breakdown of Congenital, Degenerative, Infective, Neoplastic,
Trauma, and Vascular Epilepsy
Spinal Cord Injuries Propel the Demand for Spinal Cord
Stimulation Devices
Recent Developments in Spinal Cord Injury Treatment
TENS (Transcutaneous electrical nerve stimulation devices)
Market Witnesses Rapid Growth
Non-Invasiveness of TMS (Transcranial Magnetic Stimulation)
Propelling the adoption of TMS devices
Neuromodulation Technologies to Gain Preference Over Opioids
Tibial Neuromodulation to Impact Overactive Bladder Market
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Spinal Cord Stimulation by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 2: World Historic Review for Spinal Cord Stimulation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 3: World 15-Year Perspective for Spinal Cord Stimulation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for Deep
Brain Stimulation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Deep Brain Stimulation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 6: World 15-Year Perspective for Deep Brain Stimulation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Sacral Nerve Stimulation by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Sacral Nerve Stimulation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 9: World 15-Year Perspective for Sacral Nerve Stimulation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Vagus Nerve Stimulation by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Vagus Nerve Stimulation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 12: World 15-Year Perspective for Vagus Nerve Stimulation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Transcutaneous Electrical Nerve Stimulation by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Transcutaneous Electrical
Nerve Stimulation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Transcutaneous
Electrical Nerve Stimulation by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Repetitive Transcranial Magnetic Stimulation by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Repetitive Transcranial
Magnetic Stimulation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Repetitive Transcranial
Magnetic Stimulation by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 21: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 22: World Recent Past, Current & Future Analysis for
Chronic Pain by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 23: World Historic Review for Chronic Pain by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Chronic Pain by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 25: World Recent Past, Current & Future Analysis for
Failed Back Syndrome by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for Failed Back Syndrome by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 27: World 15-Year Perspective for Failed Back Syndrome by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 28: World Recent Past, Current & Future Analysis for
Depression by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 29: World Historic Review for Depression by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Depression by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 31: World Recent Past, Current & Future Analysis for
Epilepsy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 32: World Historic Review for Epilepsy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 33: World 15-Year Perspective for Epilepsy by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 34: World Recent Past, Current & Future Analysis for
Parkinson`s Disease by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 35: World Historic Review for Parkinson`s Disease by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 36: World 15-Year Perspective for Parkinson`s Disease by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 37: World Recent Past, Current & Future Analysis for
Migraine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 38: World Historic Review for Migraine by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 39: World 15-Year Perspective for Migraine by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 40: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 41: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 42: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 43: World Recent Past, Current & Future Analysis for
Neuromodulation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 44: World Historic Review for Neuromodulation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 45: World 15-Year Perspective for Neuromodulation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Neuromodulation Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2022 (E)
Table 46: USA Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 47: USA Historic Review for Neuromodulation by Technology -
Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 48: USA 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 49: USA Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 50: USA Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 51: USA 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
CANADA
Table 52: Canada Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Canada Historic Review for Neuromodulation by
Technology - Spinal Cord Stimulation, Deep Brain Stimulation,
Sacral Nerve Stimulation, Vagus Nerve Stimulation,
Transcutaneous Electrical Nerve Stimulation, Repetitive
Transcranial Magnetic Stimulation and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 54: Canada 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 55: Canada Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 56: Canada Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 57: Canada 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
JAPAN
Neuromodulation Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2022 (E)
Table 58: Japan Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 59: Japan Historic Review for Neuromodulation by
Technology - Spinal Cord Stimulation, Deep Brain Stimulation,
Sacral Nerve Stimulation, Vagus Nerve Stimulation,
Transcutaneous Electrical Nerve Stimulation, Repetitive
Transcranial Magnetic Stimulation and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 60: Japan 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 61: Japan Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Japan Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 63: Japan 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
CHINA
Neuromodulation Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2022 (E)
Table 64: China Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 65: China Historic Review for Neuromodulation by
Technology - Spinal Cord Stimulation, Deep Brain Stimulation,
Sacral Nerve Stimulation, Vagus Nerve Stimulation,
Transcutaneous Electrical Nerve Stimulation, Repetitive
Transcranial Magnetic Stimulation and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 66: China 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 67: China Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 68: China Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 69: China 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
EUROPE
Neuromodulation Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2022 (E)
Table 70: Europe Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 71: Europe Historic Review for Neuromodulation by
Technology - Spinal Cord Stimulation, Deep Brain Stimulation,
Sacral Nerve Stimulation, Vagus Nerve Stimulation,
Transcutaneous Electrical Nerve Stimulation, Repetitive
Transcranial Magnetic Stimulation and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 72: Europe 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 73: Europe Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 74: Europe Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 75: Europe 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
Table 76: Europe Recent Past, Current & Future Analysis for
Neuromodulation by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 77: Europe Historic Review for Neuromodulation by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 78: Europe 15-Year Perspective for Neuromodulation by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2021 & 2027
FRANCE
Neuromodulation Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2022 (E)
Table 79: France Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 80: France Historic Review for Neuromodulation by
Technology - Spinal Cord Stimulation, Deep Brain Stimulation,
Sacral Nerve Stimulation, Vagus Nerve Stimulation,
Transcutaneous Electrical Nerve Stimulation, Repetitive
Transcranial Magnetic Stimulation and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 81: France 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 82: France Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 83: France Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 84: France 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
GERMANY
Neuromodulation Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2022 (E)
Table 85: Germany Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 86: Germany Historic Review for Neuromodulation by
Technology - Spinal Cord Stimulation, Deep Brain Stimulation,
Sacral Nerve Stimulation, Vagus Nerve Stimulation,
Transcutaneous Electrical Nerve Stimulation, Repetitive
Transcranial Magnetic Stimulation and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 87: Germany 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 88: Germany Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 89: Germany Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 90: Germany 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
ITALY
Table 91: Italy Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Stimulation, Transcutaneous Electrical Nerve Stimulation,
Repetitive Transcranial Magnetic Stimulation and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 92: Italy Historic Review for Neuromodulation by
Technology - Spinal Cord Stimulation, Deep Brain Stimulation,
Sacral Nerve Stimulation, Vagus Nerve Stimulation,
Transcutaneous Electrical Nerve Stimulation, Repetitive
Transcranial Magnetic Stimulation and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 93: Italy 15-Year Perspective for Neuromodulation by
Technology - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation, Deep Brain Stimulation, Sacral Nerve
Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical
Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation
and Other Technologies for the Years 2012, 2021 & 2027
Table 94: Italy Recent Past, Current & Future Analysis for
Neuromodulation by Application - Chronic Pain, Failed Back
Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 95: Italy Historic Review for Neuromodulation by
Application - Chronic Pain, Failed Back Syndrome, Depression,
Epilepsy, Parkinson`s Disease, Migraine and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 96: Italy 15-Year Perspective for Neuromodulation by
Application - Percentage Breakdown of Value Sales for Chronic
Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s
Disease, Migraine and Other Applications for the Years 2012,
2021 & 2027
UNITED KINGDOM
Neuromodulation Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2022 (E)
Table 97: UK Recent Past, Current & Future Analysis for
Neuromodulation by Technology - Spinal Cord Stimulation, Deep
Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957502/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
